Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.23 Analyst target: $10.00 Upside: 713.01%
Silo Pharma Inc. is a pioneering biopharmaceutical company dedicated to innovating therapeutics by integrating traditional treatment approaches with psychedelic research, focusing on mental health disorders and rare diseases. Utilizing its proprietary drug delivery technologies and forming strategic alliances, Silo aims to ensure the responsible clinical application of psychedelics within a regulatory framework. With a promising pipeline of candidates addressing significant unmet medical needs, Silo Pharma is well-positioned to capitalize on the growing interest in mental health therapeutics, offering potential value creation for investors in this dynamic sector.
See the full interactive analysis & chart →Informational only — not investment advice.